M
Maccura Biotechnology Co Ltd
SZSE:300463
Maccura Biotechnology Co Ltd
SZSE:300463
Price:
13.19 CNY
-1.2%
Updated:
May 16, 2024
P/S
Price to Sales
Price to Sales
2.8
Current
3.2
Median
4
Industry
Lower
than median
Lower
than industry value
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
P/S
=2.8
Market Cap
/
8B
Revenue
2.8B
All Countries
| Market Cap | P/S | ||||
|---|---|---|---|---|---|
| CN |
M
|
Maccura Biotechnology Co Ltd
SZSE:300463
|
8B CNY | 2.8 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
231.7B USD | 5.4 | |
| US |
|
Danaher Corp
NYSE:DHR
|
195.1B USD | 4.5 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
45.2B USD | 6.7 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
42.4B USD | 2.8 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
38.3B CHF | 5.7 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
55.6T KRW | 15 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
32.5B USD | 8.6 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
26.6B USD | 3.2 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
25.6B USD | 8.8 | |
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
19.8B EUR | 7.3 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/S
2.5
2-Years Forward
P/S
2.2
3-Years Forward
P/S
N/A
You don't have any saved screeners yet
